☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Zealand
Zealand Entered into a License and Development Agreement with Novo Nordisk for Zegalogue (dasiglucagon) to Treat Diabetes
September 7, 2022
Zealand Reports Results of Dasiglucagon in P-III (17103) Trial for the Treatment of Congenital Hyperinsulinism in Pediatric Patien...
May 20, 2022
Insights+: The US FDA New Drug Approvals in March 2021
April 15, 2021
PharmaShots Weekly Snapshots (Mar 22 - 26, 2021)
March 26, 2021
Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value
February 11, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.